176 related articles for article (PubMed ID: 35986958)
1. Potential of targeting host cell calcium dynamics to curtail SARS-CoV-2 infection and COVID-19 pathogenesis.
Sultan F; Ahuja K; Motiani RK
Cell Calcium; 2022 Sep; 106():102637. PubMed ID: 35986958
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of host cell calcium signaling during viral infections: Emerging paradigm with high clinical relevance.
Saurav S; Tanwar J; Ahuja K; Motiani RK
Mol Aspects Med; 2021 Oct; 81():101004. PubMed ID: 34304899
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and the reduction of SARS-CoV-2 infection through regulation of host cell calcium dynamics.
Endo HM; Bandeca SCS; Olchanheski LR; Schemczssen-Graeff Z; Pileggi M
Life Sci; 2024 Aug; 350():122784. PubMed ID: 38848939
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
5. Calcium Channel Blockers: A Possible Potential Therapeutic Strategy for the Treatment of Alzheimer's Dementia Patients with SARS-CoV-2 Infection.
Danta CC
ACS Chem Neurosci; 2020 Aug; 11(15):2145-2148. PubMed ID: 32662982
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
Dakal TC
Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Prasada Kabekkodu S; Chakrabarty S; Jayaram P; Mallya S; Thangaraj K; Singh KK; Satyamoorthy K
Mitochondrion; 2023 Mar; 69():43-56. PubMed ID: 36690315
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.
Seyedpour S; Khodaei B; Loghman AH; Seyedpour N; Kisomi MF; Balibegloo M; Nezamabadi SS; Gholami B; Saghazadeh A; Rezaei N
J Cell Physiol; 2021 Apr; 236(4):2364-2392. PubMed ID: 32901936
[TBL] [Abstract][Full Text] [Related]
9. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.
Yang CY; Chen YH; Liu PJ; Hu WC; Lu KC; Tsai KW
Int J Med Sci; 2022; 19(8):1340-1356. PubMed ID: 35928726
[TBL] [Abstract][Full Text] [Related]
11. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
Wu B; Ramaiah A; Garcia G; Hasiakos S; Arumugaswami V; Srikanth S
J Immunol; 2022 Jan; 208(1):74-84. PubMed ID: 34819389
[TBL] [Abstract][Full Text] [Related]
12. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
13. Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19.
Wang M; Chang W; Zhang L; Zhang Y
Int J Biol Sci; 2022; 18(15):5827-5848. PubMed ID: 36263178
[TBL] [Abstract][Full Text] [Related]
14. Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Cloherty APM; Rader AG; Patel KS; Pérez-Vargas J; Thompson CAH; Ennis S; Niikura M; Wildenberg ME; Muncan V; Schreurs RRCE; Jean F; Ribeiro CMS
Emerg Microbes Infect; 2023 Dec; 12(1):2195020. PubMed ID: 36951188
[TBL] [Abstract][Full Text] [Related]
15. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
[TBL] [Abstract][Full Text] [Related]
16. Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.
Cariou M; Picard L; Guéguen L; Jacquet S; Cimarelli A; Fregoso OI; Molaro A; Navratil V; Etienne L
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2206610119. PubMed ID: 35947637
[TBL] [Abstract][Full Text] [Related]
17. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein.
Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI
mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.
Panda M; Kalita E; Singh S; Kumar K; Rao A; Prajapati VK
Life Sci; 2022 Sep; 305():120761. PubMed ID: 35787998
[TBL] [Abstract][Full Text] [Related]
20. Host polymorphisms and COVID-19 infection.
Delanghe JR; Speeckaert MM
Adv Clin Chem; 2022; 107():41-77. PubMed ID: 35337605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
